- Patent Title: Compound bearing beta-galactoside-introduced self-immolative linker
-
Application No.: US16472983Application Date: 2017-12-28
-
Publication No.: US11065343B2Publication Date: 2021-07-20
- Inventor: Tae Kyo Park , Sung Ho Woo , Sun Young Kim , Doo Hwan Jung , Sang Kwang Lee , Jong Un Cho , Jae Ho Lee , Su Ho Park , Dong Hoon Seo , Hyang Sook Lee , Beom Seok Seo , Ji Yeon Lim
- Applicant: IntoCell Inc.
- Applicant Address: KR Daejeon
- Assignee: IntoCell Inc.
- Current Assignee: IntoCell Inc.
- Current Assignee Address: KR Daejeon
- Agency: The Webb Law Firm
- Priority: KR10-2016-0180628 20161228,KR10-2017-0181411 20171227
- International Application: PCT/KR2017/015613 WO 20171228
- International Announcement: WO2018/124758 WO 20180705
- Main IPC: A61K47/68
- IPC: A61K47/68 ; A61K47/54 ; A61K45/06 ; A61K31/40 ; C07K16/32 ; A61K47/64

Abstract:
The present invention relates to a compound bearing a self-immolative linker having β-galactoside-introduced thereto. In a compound bearing a β-galactoside-introduced self-immolative linker according to the present invention, particularly, the self-immolative linker may form a glycosidic bond with a protein (e.g., an oligopeptide, polypeptide, an antibody, etc.) or ligand which has specific affinity for a desired target or with an active agent (e.g., a drug, a toxin, a ligand, a detection probe, etc.), which has a specific function or activity so as to allow the selective release of the active agent within a target cell.
Public/Granted literature
- US20190328902A1 Compound Bearing Beta-Galactoside-Introduced Self-Immolative Linker Public/Granted day:2019-10-31
Information query
IPC分类: